Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159.62 USD | +0.35% | +2.05% | +1.60% |
Jan. 16 | AptarGroup, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-16-2025 09:45 AM | |
Jan. 07 | Raymond James Initiates AptarGroup at Outperform With $200 Price Target | MT |
Capitalization | 10.62B 10.2B 9.64B 8.61B 15.27B 918B 16.92B 117B 43.01B 379B 39.83B 39.02B 1,657B | P/E ratio 2024 * |
30.8x | P/E ratio 2025 * | 28.3x |
---|---|---|---|---|---|
Enterprise value | 11.37B 10.92B 10.32B 9.21B 16.34B 983B 18.11B 125B 46.03B 405B 42.62B 41.76B 1,773B | EV / Sales 2024 * |
3.17x | EV / Sales 2025 * | 3.01x |
Free-Float |
91.47% | Yield 2024 * |
1.1% | Yield 2025 * | 1.19% |
Last Transcript: AptarGroup, Inc.
1 day | +0.35% | ||
1 week | +2.05% | ||
Current month | +1.60% | ||
1 month | +0.69% | ||
3 months | -4.79% | ||
6 months | +9.30% | ||
Current year | +1.60% |
Director | Title | Age | Since |
---|---|---|---|
Stephan Tanda
CEO | Chief Executive Officer | 59 | 2017-01-31 |
Vanessa Kanu
DFI | Director of Finance/CFO | 48 | 2024-12-31 |
Mary Skafidas
IRC | Investor Relations Contact | - | - |
Manager | Title | Age | Since |
---|---|---|---|
Ralf Wunderlich
BRD | Director/Board Member | 59 | 2008-12-31 |
Director/Board Member | 68 | 2009-12-31 | |
George Fotiades
CHM | Chairman | 71 | 2018-05-01 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.35% | +2.05% | +21.08% | +37.15% | 10.62B | ||
+0.51% | +0.72% | +3.17% | -18.24% | 14.07B | ||
+0.66% | +1.26% | +1.89% | -1.05% | 7.92B | ||
+1.89% | +5.56% | +20.97% | +125.56% | 1.46B | ||
-0.49% | -1.23% | +0.50% | -12.01% | 1.42B | ||
+2.08% | +3.46% | -1.17% | -23.73% | 1.44B | ||
-1.08% | 0.00% | +48.27% | -16.51% | 1.34B | ||
-0.50% | 0.00% | +19.35% | -32.72% | 1.33B | ||
-1.95% | -9.37% | +132.66% | +373.61% | 1.05B | ||
0.00% | -0.39% | +19.62% | +40.72% | 851M | ||
Average | +0.15% | -0.25% | +26.63% | +47.28% | 4.15B | |
Weighted average by Cap. | +0.41% | +0.90% | +13.48% | +15.00% |
2024 * | 2025 * | |
---|---|---|
Net sales | 3.59B 3.45B 3.26B 2.91B 5.16B 310B 5.72B 39.54B 14.54B 128B 13.46B 13.19B 560B | 3.75B 3.6B 3.41B 3.04B 5.39B 324B 5.97B 41.32B 15.19B 134B 14.06B 13.78B 585B |
Net income | 346M 333M 314M 281M 498M 29.92B 551M 3.81B 1.4B 12.34B 1.3B 1.27B 54B | 377M 362M 343M 306M 543M 32.62B 601M 4.16B 1.53B 13.45B 1.41B 1.39B 58.86B |
Net Debt | 746M 717M 677M 605M 1.07B 64.48B 1.19B 8.22B 3.02B 26.59B 2.8B 2.74B 116B | 651M 625M 591M 528M 936M 56.27B 1.04B 7.17B 2.64B 23.2B 2.44B 2.39B 102B |
Date | Price | Change | Volume |
---|---|---|---|
25-01-23 | 159.62 $ | +0.35% | 149,812 |
25-01-22 | 159.07 $ | -0.48% | 279,989 |
25-01-21 | 159.83 $ | +2.40% | 270,874 |
25-01-17 | 156.09 $ | -0.20% | 231,872 |
25-01-16 | 156.41 $ | +0.55% | 346,317 |
Delayed Quote Nyse, January 23, 2025 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ATR Stock